Clinical Research
corporate_fare

Otsuka Pharmaceutical Co. Ltd.

Address
2 9 Kanda Tsukasamachi, Chiyodo Ku

Sponsor Overview

assignment
1
sponsored trial
science
2
molecules
location_city
8
research centres
public
1
country
person_search
11
investigators

Specializations

Psychiatric Disorders

Research activity is centered on acute schizophrenia, with interest in symptom control and treatment options for patients experiencing acute episodes.

  • Schizophrenia
  • Acute psychosis
  • Psychiatric symptom management

The clinical focus includes therapeutic development for severe mental illness within neuropsychiatry.

Neuropsychiatric Therapeutics

The sponsor’s trial portfolio reflects interest in treatments targeting central nervous system conditions, particularly agents intended to address acute behavioral and cognitive disturbances associated with schizophrenia.

  • Central nervous system disorders
  • Antipsychotic therapy
  • Behavioral symptom control

Work in this area aligns with the development of medicines for mental health disorders requiring ongoing clinical evaluation.

Long-Acting Antipsychotic Treatment

Clinical interest includes formulations designed for sustained treatment delivery in schizophrenia, with attention to once-weekly administration approaches for antipsychotic care.

  • Long-acting formulations
  • Once-weekly dosing
  • Treatment adherence

This therapeutic domain is relevant to patients who may benefit from simplified maintenance strategies in psychiatric treatment.

Clinical Development in Mental Health

The sponsor is active in clinical research for mental health disorders, with a focus on evaluating therapies for acute symptom relief and broader psychiatric care.

  • Acute symptom treatment
  • Psychiatric care
  • Therapeutic innovation

Its research activity is concentrated in Japan, involving multiple collaborating sites for the study of schizophrenia-related therapies.

Sponsored Trials

Trial Name Country Status
A multicenter, placebo-controlled, randomized, double-blind, parallel-group comparison trial to investigate the efficacy and safety of brexpiprazole once-weekly (QW) formulation in patients with acute schizophreniaRomania RomaniaRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 2 total (50% not shared with other sponsors)

This sponsor works with 2 molecules, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 8 sites collaborated multiple times

This sponsor has worked with 8 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Mental Disorders1 trial
    150 other sponsors

Partnered Research Centres

8 centres
location_city
assignment16
Centru De Evaluare Si Tratament A Toxicodependentelor Pentru Tineri Sf. Stelian
Address
Strada Ing Cristian Pascal 25-27 Sector 6, 060222 Bucharest
Learn morearrow_forward
location_city
assignment65
Emergency Institute For Cardiovascular Diseases And Transplant
Address
Strada Marinescu Gheorghe 50, 540136 Târgu Mureş
Learn morearrow_forward
location_city
assignment20
Institutul De Psihiatrie Socola Lasi
Address
Soseaua Bucium 36, 700282 Iasi
Learn morearrow_forward
location_city
assignment41
Spitalul Clinic De Psihiatrie Prof.Dr.Alexandru Obregia
Address
Strada Argeselu Nr 8, 040874 Bucharest
Learn morearrow_forward
location_city
assignment17
Spitalul Clinic De Psihiatrie Si Neurologie Brasov
Address
Strada Prundului 7-9, 500123 Brasov
Learn morearrow_forward
location_city
assignment7
Spitalul Clinic de Psihiatrie “Dr. Gheorghe Preda” Sibiu
Address
Strada Doctor Dumitru Bagdazar Nr 12, 550082 Sibiu
Learn morearrow_forward
Page 1 of 2

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Otsuka Pharmaceutical Co. Ltd..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.